Global Hyaluronic Acid Based Dermal Fillers Market Size study & Forecast, by Crosslinking Type (Monophasic, Biphasic) by Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, Others), by End-user (Spec

Global Hyaluronic Acid Based Dermal Fillers Market Size study & Forecast, by Crosslinking Type (Monophasic, Biphasic) by Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, Others), by End-user (Specialty & Dermatology Clinics, Hospitals & Clinics, Others) and Regional Analysis, 2022-2029

Global Hyaluronic Acid Based Dermal Fillers Market is valued at approximately USD 3.89 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2022-2029. Hyaluronic acid (HA) dermal fillers also known as hyaluronan are non-permanent injectable materials that are used for the correction of soft tissue defects of the face. Hyaluronic acid dermal fillers are available in two varieties: biphasic and monophasic. The increasing number of dermatology clinics, surging demand for invasive injection of dermal fillers to remove wrinkles, and the rising demand for HA-based dermal fillers procedures and the introduction of products are the primary factors that are propelling the market demand across the globe.

The surging demand for minimally invasive facial treatments and high preference towards HA-based Dermal Fillers Procedures is directly associated with the market demand in the global market. The Plastic Surgery Statistics Report stated that it was estimated that in the United States, there are around total cosmetic minimally invasive procedures using HA fillers 2.13 million in 2018 and the figure increased to 2.88 million in 2019. Similarly,, according to data provided by the International Society of Aesthetic Plastic Surgery (ISAPS), 4.32 million operations with hyaluronic acid-based dermal fillers were performed worldwide in 2019. 3.82 million procedures were recorded among women. Thereby, the rising inclination towards minimally invasive facial treatments is stimulating the growth of the hyaluronic acid-based dermal fillers market. Moreover, the rising demand for invasive injections of dermal fillers, as well as the increasing number of dermatology clinics are presenting various lucrative opportunities over the forecasting years. However, the presence of alternative dermal fillers and the high cost of dermal filling operations are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Hyaluronic Acid Based Dermal Fillers Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the presence of well-established healthcare infrastructure, rising adoption of monophasic, and extensive R&D initiatives by leading players. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as increasing fillers procedures, growing production of target products, and rising awareness regarding the application of HA-based dermal fillers in the market space.

Major market players included in this report are:
Allergan Aesthetics (AbbVie Inc.)
Revance Therapeutics, Inc.
Merz Pharma GmbH & Co. KGaA
Galderma
Sinclair Pharma
Bioplus Co., Ltd.
Bioxis Pharmaceuticals
Dr. Korman Laboratories Ltd.
Prollenium Medical Technologies
Teoxane SA

Recent Developments in the Market:
 In February 2022, Allergan Aesthetics (AbbVie, Inc.) announced that the company received the U.S. FDA approval for JUVÉDERM VOLBELLA XC to improve infraorbital hollows for adults over the age of 21.
 In December 2021, Revance Therapeutics, Inc. announced that the company received the U.S. FDA approval for its RHA Redensity dermal filler for the treatment of perioral rhytids (lip lines).


Global Hyaluronic Acid Based Dermal Fillers Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Crosslinking Type, Application, End-user, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:

By Crosslinking Type:
Monophasic
Biphasic
By Application:
Scar Treatment
Wrinkle Correction Treatment
Lip Enhancement
Restoration of Volume/Fullness
Others
By End-user:
Specialty & Dermatology Clinics
Hospitals & Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Allergan Aesthetics (AbbVie Inc.)
Revance Therapeutics, Inc.
Merz Pharma GmbH & Co. KGaA
Galderma
Sinclair Pharma
Bioplus Co., Ltd.
Bioxis Pharmaceuticals
Dr. Korman Laboratories Ltd.
Prollenium Medical Technologies
Teoxane SA

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.